API

PO API Capsule | API Pharmaceutical Outsourcing

An active pharmaceutical ingredient (API) is defined in ICH Q7 as “any substance or mixture of substances intended to be used in the manufacture of a drug product and that, when used in the production of a drug, becomes an active ingredient in the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the body.”

Active pharmaceutical ingredients are distinguishable from inactive pharmaceutical ingredients, commonly known as excipients or formulation aids.

The European Medicines Agency, and the US FDA have adopted the ICH Q7 definition of APIs.

Many other terms are used interchangeably with API. They include:

  • active
  • bulk pharmaceutical chemical
  • drug substance
  • active principle (especially for natural extracts)
  • therapeutic ingredient

Filter

Hide Filter
  • Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer

    Thursday, March 15, 2012
    Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ... read more
  • INC Research to Discuss Global Partnerships and Future Trends

    Tuesday, February 28, 2012
    INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ... read more
  • Boehringer Ingelheim and Xencor Enter a Collaboration Agreement

    Tuesday, February 21, 2012
    Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ... read more
  • Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC

    Friday, February 17, 2012
    Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the... read more
  • Ockham Completes Acquisition of Nexus Oncology

    Thursday, February 16, 2012
    Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner. read more
  • One Year On…Almac Doubles Analytical Capacity in US Headquarters

    Thursday, February 09, 2012
    Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ... read more
  • INC Research Releases New White Paper

    Wednesday, February 08, 2012
    INC Research , LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The... read more
  • Pharma and Biotech Services

    Sunday, January 01, 2012
    Bachem is a technology-based biochemicals company providing full service to the pharma and biotech industry. Bachem specializes in the manufacture of peptides and complex organic molecules as APIs, as well as innovative biochemicals for research ... read more
  • Late-stage API Development, Manufacturing, and CMO Relations

    Sunday, January 01, 2012
    Late-stage Development and first manufacture represent critical phases for a new API. Outsourcing these complicated tasks adds an additional layer of complexity. Chemistry that has been of secondary importance becomes the highest priority and faces ... read more
  • Custom Peptide Synthesis and API Production

    Sunday, January 01, 2012
    American Peptide Company, Inc. (APC) offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide Active Pharmaceutical Ingredients. Our California based manufacturing facilities offer synthesis services ... read more
  • Pediatric Drug Development

    Tuesday, November 01, 2011
    Pediatric research is ethically challenging, requiring protection of children from potentially harmful exposure while encouraging drug development and pediatric labeling. read more
  • Pediatric Drug Safety Studies

    Thursday, September 01, 2011
    Safety studies are required for all drugs undergoing testing in pediatric patients. While efficacy can be extrapolated in some cases on the basis of adult studies, safety studies must be separately conducted in pediatric patients. read more
  • Ethics of Performing Pediatric Clinical Trials

    Thursday, September 01, 2011
    The purpose of this review is to discuss general issues that need to be taken into consideration when planning a pediatric study. read more
  • Strategies for Improving the Onsite Management of Scientific Sample Assets

    Thursday, September 01, 2011
    Effectively managing biospecimens along with their associated data are key components of efficient clinical development. read more
  • Establishing a Vendor Network for Clinical Supply Manufacturing Services

    Thursday, September 01, 2011
    The Request for Information/Request for Proposal (RFI/RFP) process for evaluating sourcing partners is well established and has been successfully utilized within the Pharmaceutical Industry. read more